Rapidly Ageing Population in Europe Boosts Prospects of Assisted Living Technologies Markets

An increasing ageing population and the associated need for healthcare services have heightened government attention on assisted living technologies, promoting the growth of this market in Europe. Early stages of technological and market development and limited awareness about the advantages of assisted living technologies threaten growth prospects. However, product customisation will help mitigate these challenges.

New analysis from Frost & Sullivan, European Markets for Assisted Living Technologies, finds that the markets earned revenues of $154.92 million in 2009 and estimates this to reach $525.58 million in 2015. The research closely examines assisted living devices for use in residences and institutions.

"A rapidly expanding elderly population in Europe is driving the need for continuous care, with mitigating this challenge featuring high on the agenda of governments in several European countries," notes Frost & Sullivan Research Analyst Somsainathan. "Governments are keen to address the needs of the elderly and provide the right social care to reduce the healthcare costs involved. Such trends are spurring the development of the market for assisted living technologies."

Rising awareness, coupled with the burgeoning need for assisted living technologies, are motivating market advancement. Participants are keen on capitalising on the end-user acceptance of these technologies and augmenting their shares in a market that is becoming increasingly competitive.

The market is developing at a brisk pace, surpassing the general healthcare industry average, mainly due to the spiralling demand for assisted living technologies. The increasing recognition of assisted living technologies is allowing participants to penetrate into the market with ease. Competition is intensifying rapidly, encouraging market participants to expand their geographic scope and improve their product portfolio.

However, high initial costs and shrinking budgets are the most important challenges for market participants. Similarly, the privacy and confidentiality issues involved have made end users reluctant to adopt such solutions.

"The high initial costs involved in setting up assisted living services have been paralleled by the post-recession phase which has led to shrinking healthcare budgets," explains Somsainathan. "Moreover, confidentiality and privacy issues in terms of data collected about end users have made many end users wary about adopting such technologies."

Product customisation and developing user-friendly technologies are key to boosting market penetration. A proper understanding of client needs will help design the right solutions, especially when the target client pool are the elderly who, in general, are sceptical of technological devices.

"Developing technologies that are user-friendly and marketable to the elderly population is critical to maintaining growth momentum," concludes Somsainathan. "Understanding client needs and ensuring product customisation based on this information will ensure success for assisted living technologies."

If you are interested in more information on Frost & Sullivan's latest study on European Markets for Assisted Living Technologies, please send an e-mail to Katja Feick, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it., with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European Markets for Assisted Living Technologies is part of the Patient Monitoring Growth Partnership Services programme, which also includes research in the following markets: Data Management Systems for Patient Monitoring Markets in Europe, European Market for non- Invasive Blood Pressure Monitors, European Telemetry Equipment Market and European Pulse Oximetry Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...